SlideShare a Scribd company logo
1 of 59
Download to read offline
Strategies for Life Under the
New USPTO Rules on
Continuation and Claims Practice


Elizabeth Haanes, Ph.D., Esq.
Mike Messinger, Esq.
Michele A. Cimbala Ph.D., Esq.
September 18, 2007
Strategies for Life Under the New
USPTO Rules

• Rational Responses
  – Sell All Your Belongings
  – Stop Innovating and
  – Live in a Cave
Notice of Final Rulemaking

• “Changes to Practice for Continued
  Examination Filings, Patent
  Applications Containing Patentably
  Indistinct Claims, and Examination
  of Claims in Patent Applications”
  – 72 Fed. Reg. 46716 (August 21, 2007)

• Effective: November 1, 2007 (but
  much is retroactive)
Key Provisions
• The number of examined claims will be
  limited (Rule 75)
• The number of continuation or CIP
  applications in a family will be limited,
  and voluntary divisional applications will
  not be allowed (Rule 78(d))
• Only one RCE per application family
  (Rule 114)
• Applicants will be required to identify
  certain copending, commonly-owned
  applications which share a common
  inventor (Rule 78(f))
The Good News...
• Excess claim fees paid for unexamined,
  canceled claims will be refunded upon
  request
• Applicants may now propose a
  “suggested restriction requirement”
  (SRR) to the Examiner
• Streamlined Continuations – may
  request continuations to be placed on
  Examiner’s Amended Docket
The Bad News...

• Only 5 independent and 25 total claims
  will be examined in any application
  without an “examination support
  document” (ESD)
• Commonly owned applications with
  common subject matter, a common
  inventor, or both, must be identified
• Typically only two continuation or CIP
  applications and one RCE per family “as
  of right”
• No voluntary divisional applications
The REALLY Bad News


• Examination Support Documents

• Copending applications determined
  to have “patentably indistinct”
  claims will be combined to meet the
  5/25 claim rule
SKGF is Here to Help You!
What We are Doing Already

• First Client Advisory Letter (Aug. 30)
• Second Client Advisory Letter (in draft)
• Triaged File Review
• Staffing
• Automation
   – Support for New Search Queries and
     Reports
• Docketing
   – New Rules and Dates
• Internal and External Training
• Frequent Involvement with USPTO
Rule 75 - Claims
• The maximum number of examined claims
  per “non-allowed” application as a matter of
  right:
   – 5 independent claims
   – 25 total claims
• An “Examination Support Document” (ESD)
  under 37 C.F.R. 1.265 must be submitted if
  you are not in compliance with Rule 75
• Withdrawn claims do not count against the
  5/25 limit unless they are reinstated or
  rejoined
Rule 75 - Claims
• The number of claims in applications that
  are co-owned and that contain at least
  one “patentably indistinct” claim will be
  added together for the purposes of
  counting the total number of claims.
• Once an application is allowed, a
  continuing application (CON or CIP) can
  be filed with another set of claims that
  complies with the 5/25 rule (“serial
  continuations”)
• Reissue applications must comply with
  the 5/25 limit.
Rule 75 - Claims

• If two or more pending, co-owned
  applications contain patentably
  indistinct claims, the USPTO will
  require the combined claims in
  those applications to meet the 5/25
  limit
Rule 75

• If the application is not in compliance
  with Rule 75 and it appears this was
  inadvertent, Applicant will be sent a
  notice with a 2 month period (not
  extendable) to:
   – supply an ESD;
   – Cancel claims; or
   – Submit a suggested restriction
      accompanied by an election without
      traverse to an invention drawn to a
      group that is in compliance.
Rule 75 is “Retroactive”

• applies to any application that has
  not yet received a first office action
  on the merits (“FAOM”) by
  November 1, 2007
Ways Around 5/25

• Prosecute CONs Serially – File
  after Parent Allowed
• SRR
• ESD
Suggested Restriction
Requirements (SRR)
• New practice under rule 142 --
  Applicant can submit a suggested
  restriction requirement (SRR) BUT
  – It must be filed prior to the first action
    on merits or first action that contains a
    restriction or lack of unity
  – An SRR must be accompanied by an
    election without traverse of an
    invention that complies with the 5/25
    claim number requirement
SRRs

• The Examiner can:
  – accept the SRR and commence
    examination on the elected group of
    claims;
  – reject the SRR and issue a different
    restriction requirement (Applicant
    must elect a group of claims and
    conform limit claims to 5/25); or
  – or reject the SRR and issue NO
    restriction requirement (Applicant
    must then limit claims to 5/25)
Rule 265: Examination Support
Document Requirements
• A statement that a preexamination search has
  been conducted
• A listing of references deemed most closely
  related to the subject matter of each claim
• For each reference an identification of all of the
  limitations of each of the claims that are
  disclosed by the reference
• A detailed explanation of how each of the
  independent claims is patentable over the cited
  references
• A showing of where each limitation of each of
  the claims finds enablement and written
  description support in the specification and any
  priority applications
ESD Recommendation

• Avoid them where possible
• Expensive and ripe for estoppel
• May have to file Supplemental
  ESD(s)
• See new ESD Guidelines issued
  Sept. 6
More Strategy Recommendations –
Claims Practice
• Currently pending cases:
   – After FINAL and RCE - Consider RCE by
     Nov. 1
   – After First Action on Merits – no claims
     limit yet – watch out if next action is
     expected to be a final
   – If restriction requirement pending, reply
     ASAP to try to receive first action on the
     merits prior to Nov. 1, 2007
   – No FAOM issued prior to Nov. 1, 2007:
       • Consider SRR and election
Strategy Recommendations

•   Future cases – new filings
     – Keep in mind 5/25 limit for appl. and 15/75 limit for appl. family
     – Draft claims with an eye toward restriction and divisional filings
     – PTO wants generic claims fully prosecuted first

•   Thin or Fat Initial Applications?
     – File Multiple Thin Initial Applications on same or different dates
          • Catch – ID requirement, Possible Merger, Terminal Disclaimer + Show
            why applications cannot be in one application
     – File Single Fat Application with many claims
          • Catch – SRR/Divisionals at Examiner’s discretion, SRR may have to
            argue one-way distinctness

•   No easy solution where substantial amount of overlapping
    material needs to be claimed

•   We will pull all this together in an example later
How will the 5/25 Rule Effect
USPTO Restriction Practice?
• Examiners may be motivated to limit the
  restrictions to reduce claims examined in
  any one application family; BUT
• Given the USPTO count system and
  time restrictions on Examiners, incentive
  remains for Examiners to issue
  restriction requirements to create more
  work on familiar applications
• Time will tell...
Identification of Copending
Applications under Rule 78(f)(1)

• Plan to be Aggravated
• Burdensome, No Way Around It
• How to Cope

• SKGF May Need Your Help
Identification of Copending
Applications under Rule 78(f)(1)
• Applicant must identify
  – all non-provisional applications/patents (that
    have not been allowed) that have benefit or
    filing dates within 2 months of each other
  – that name at least one common inventor and
  – that are owned/subject to assignment to the
    same entity
• must provide within 4 months of filing or
  entering U.S. national phase
• required even if the applications do not
  have similar subject matter
Identification of Copending
Applications under Rule 78(f)(1)
• Rule is retroactive!
• Applicants MUST comply with new rule
  78(f)(1) in ALL pending applications by:
  FEBRUARY 1, 2008.
• Intervening filing dates of
  Cons/Divs/CIPs should be considered as
  well
Treatment of Copending Applications
under Rule 78(f)(2)
• If identification under 78(f)(1)
  required AND
   - multiple applications have the same filing or
     benefit date;
   - and contain “substantial overlapping
     disclosure
- Then a rebuttable presumption exists
  that the applications each contain at
  least one claim that is not patentably
  distinct from at least one claim in the
  other application
Treatment of Copending Applications
under Rule 78(f)(2)
• Applicants must rebut the
  presumption that the claims are
  patentably indistinct; OR
• Submit a terminal disclaimer AND
  explain why the claims cannot be in
  a single application
Compliance with Rule 78(f)(2) is by
the later of
• 4 months from the filing or national
  stage entry date
• the date on which a claim that is not
  patentably distinct is presented
• two months from the date of mailing
  of the initial filing receipt in any of the
  applications
Rule 78(f)(2) is Retroactive!

• Compliance with rule 78(f)(2) for all
  pending applications is required by
  February 1, 2008
Ways Around the ID requirement
• There are none
  – Inventorship determination is a matter of law
  – Staggering filing dates may raise other
    issues
  – Big burden for complex older patent families
• What happens if we don’t comply...
  – Don’t go there intentionally
• Best route
  – Apply experienced legal talent to benefit
    claim analysis
  – Automate like crazy with oversight
  – Look at your benefit claim data NOW
SKGF Action

• Prior to Feb. 1, 2008, SKGF will
  work with clients to identify all
  pending applications which require
  cross-identification under rule 78(f)
• We will need client input as to
  whether additional applications
  (prosecuted in-house or by other
  firms) need to be identified
Domestic Benefit Claims
Rule 78(d)

(d)(1) All domestic benefit claims MUST
  satisfy at least one of (d)(1)(i) through
  (d)(1)(vi)

NB! The PTO is not responsible for its own
  errors:
(d)(1): A mistake on the part of the PTO in
  entering or in not deleting an improper
  claim does not constitute a waiver of
  Rule 78(d)(1).
Domestic Benefit Claims

The Basics:

•   Only two continuation applications “as
    of right”

•   Each divisional may have its own two
    con applns.

•   No voluntary divisionals

•   No CIP’s filed off of divisionals
Domestic Benefit Claims
Organization of Rule 78(d)

(d)(1)(i)     -   continuation appln
      (ii)    -   divisional appln
      (iii)   -   continuation of divisional appln
      (iv)    -   1st nonprov is a Chap. I PCT;
                  no fee paid and no Chap. II
  demand
     (v) - 1st nonprov appln
            was abandoned with a NTFMP
     (vi) - appln has a “petition and
  showing”
“Continuing” Applications

• A “Continuing Application” is a
  nonprovisional or PCT application
  designating the US that claims benefit of
  a prior filed nonprovisional or PCT
  application designating the US
  – Includes: continuation, divisional,
    continuation-in-part or PCT applications
  – Does NOT include:
     • A first filed nonprovisional application
     • A provisional application
     • An application that only has a benefit claim to a
       provisional application or a priority claim to a
       foreign application
Continuation Applications

Definition:

• A continuing application that
  discloses and claims only subject
  matter that was disclosed in a prior-
  filed non-provisional application
Continuation-in-Part (CIP)
Applications

• A continuing application that discloses
  subject matter that was not disclosed in
  a prior-filed non-provisional application
• Applicants must identify claims in a CIP
  that have 35 U.S.C. 112(1) support in
  the earlier-filed non-provisional
  application
• Any claim not so identified will be
  presumed to be entitled only to the filing
  date of the CIP
CIP Recommendations

• Avoid them. If claims are supported
  by the earlier-filed non-provisional
  application, use a continuation
  rather than a CIP
• If the claims would not be
  supported by the earlier-filed non-
  provisional application, consider
  filing a new application without
  claiming priority benefit
Recommendation: Postpone
“Continuing” Applications
• Now: consider converting first-filed
  U.S. nonprovisional filings to
  provisionals
• Future: file initial filings in the
  United States as provisional
  applications
“Showing” Standard for Additional
Continuing Applications
• Must include an amendment,
  argument, or evidence
• Must show that the information
  sought to be entered could not have
  been submitted during the
  prosecution of the prior-filed
  application
• Must be submitted within 4 months
  from the filing date, or national
  stage entry date, of the continuing
  application.
Divisional Applications

• A divisional application is a
  continuing application that discloses
  and claims only inventions subject to
  a lack of unity or restriction in a prior-
  filed application, and that were
  – Not elected in the prior application;
      and
  – Not examined in any prior application.
• A “voluntary divisional” is a continuation
Divisionals

• Can I rely upon a restriction
  requirement to immediately file a
  divisional?
  – Yes, if you elect without traverse, and
    cancel all non-elected claims
  – No, if you traverse the restriction,
    because there is a chance it will be
    withdrawn
  – No, if you retain non-elected claims,
    because they might be rejoined
“Not Examined in Any Prior-filed
Application”
• Does “Examined” encompass PCT
  Chapter II “preliminary examination” ?
• YES (?) NO(?) <PTO must clarify>
• Thus, during later US prosecution a
  lack of unity rejection or restriction
  requirement is made, it may not be
  possible to file a proper “divisional”
  application on claims which were
  already subject to PCT Chapter II
  preliminary examination
What if Restricted Claims Have Been
Examined?

• Elect those claims which have
  already been examined
• Traverse the restriction requirement
  and petition finality
• File the already-examined but
  restricted claims in a “continuation”
  with a petition and showing
RCEs
• Only 1 RCE as of right in any application
  family
• Additional RCEs will require a petition, fee,
  and a sufficient “showing” that the
  amendment, argument, or evidence sought to
  be submitted couldn’t have been submitted
  prior to close of prosecution in the application
• For subsequent RCEs, an IDS, by itself, is an
  insufficient “showing”
• Is it not sufficient that the Examiner raised new
  grounds of rejection in a final office action.
RCE and “After Final”
Recommendations
• NOW: if you currently have a final
  rejection and have already filed one
  RCE in the family, file a second RCE
  prior to November 1, 2007
• Going forward: petition improper final
  office actions
• Use interview practice to negotiate
  allowable claims
• If further continuations are not an
  option, amend claims to put in best
  form for appeal
Example, Continuations Filed
Before 8/21/07
                   8/21/07      11/1/07
2nd Con      Con
             Con
             Con

• Benefit claim will be ok but if not yet
  examined, will still have to comply with
  the 5/25 rule.
• Applications must comply with the
  identification requirements of Rule 78(f)
Filing Con before 11/1/07
                   8/21/07          11/1/07

2nd Con              Con
                     Con
                     Con

These are 3rd – 5th Continuations;
No “one more exception” (OME) will be available
after 11/1
5/25 will apply and also identification Rule 78(f)(1)
and (2)
The PTO can force you to combine all the
continuations.
So is it wise to file continuations
before November 1?


Filing Cons after 8/21/07 and before
11/1/07 won’t help and may hurt.
New Mindset for Focused
Examination
• Impact on New Filings and Patent Portfolio
  Creation
• Maximize Value of an Application Family (Initial
  Appl./2 CONs)
   – Target claims even better upfront
   – Consider more “story” in specification or evidence on
     non-obviousness
   – Consider more patentability searching (Seagate)
   – Know Prosecution Strategy, Desired Claim Coverage
     and Endgame Upfront
• More Pitfalls - Patent Prosecution Expertise and
  Time for Analysis Even More Important
First Example of Life Under the
New Rules
Example – Wireless Web Phone Functionality Invention
Example of Life Under the New Rules
First Example of Life Under the
New Rules
Example of Life Under the New Rules
Example – Compound Claims
Example – Compound Claims
New Mindset for Focused
Examinaton
• The New Skill Set
  – Suggesting restrictions
       • Arguing one-way distinctness
  – Petitioning Improper Final Office Action
  – Interviewing
       • before and after Office Actions if possible
  –   More Appeals to BPAI
  –   Concise Claiming
  –   Tracking Claim Count
  –   Identifying Commonly-Owned Applications
      with a Common Inventor even across
      multiple prosecution firms
To Do List – SKGF and Clients

•   Our Actions Items - SKGF and Clients
     – Now to Nov. 1, 2007
        • Get Grandfathered
            – Respond to Restriction Requirements
            – File RCEs after Final
    – Now to Feb. 1, 2008
       • Review and Collect Data for ID Req’t
    – Special Cases to Call Your Attorney
       • New Continuations to Cover Unclaimed Subject
         Matter
       • Pending Cases with Very High Claim Counts
       • Complex Benefit Claims
THANK YOU!
Elizabeth Haanes, Ph.D., Esq.
bhaanes@SKGF.com
Mike Messinger, Esq.
mikem@SKGF.com
Michele A. Cimbala, Ph.D., Esq.
mcimbala@SKGF.com




This content of this presentation by Sterne, Kessler, Goldstein & Fox P.L.L.C. is for purposes of
discussion and should not be considered legal advice.
© 2007 Sterne, Kessler, Goldstein & Fox P.L.L.C.
                                                                                 722854

More Related Content

Similar to SKGF_Advisory_Strategies for Life Under the New USPTO Rules on Continuation and Claims Practice_2007

Five major differences between IPRs and invalidation proceedings
Five major differences between IPRs and invalidation proceedingsFive major differences between IPRs and invalidation proceedings
Five major differences between IPRs and invalidation proceedingsAlexandraPuYang
 
ANALYSIS OF PATENTS POST APPROVAL
ANALYSIS OF PATENTS POST APPROVALANALYSIS OF PATENTS POST APPROVAL
ANALYSIS OF PATENTS POST APPROVALARPUTHA SELVARAJ A
 
How to Get the Patent Protection VCs Crave and Cut Patent-Related Costs by 90%!
How to Get the Patent Protection VCs Crave and Cut Patent-Related Costs by 90%!How to Get the Patent Protection VCs Crave and Cut Patent-Related Costs by 90%!
How to Get the Patent Protection VCs Crave and Cut Patent-Related Costs by 90%!ideatoipo
 
15 March 2016 - Law Institute of Victoria conference presentation.
15 March 2016 - Law Institute of Victoria conference presentation.15 March 2016 - Law Institute of Victoria conference presentation.
15 March 2016 - Law Institute of Victoria conference presentation.Andrew Downie
 
Georgetown Univ. Law Center Conference: Post-Grant Patent Proceedings: Are th...
Georgetown Univ. Law Center Conference: Post-Grant Patent Proceedings: Are th...Georgetown Univ. Law Center Conference: Post-Grant Patent Proceedings: Are th...
Georgetown Univ. Law Center Conference: Post-Grant Patent Proceedings: Are th...WilmerHale
 
How to Get the Patent Protection VCs Crave and Cut Patent-Related Costs by 90%!
How to Get the Patent Protection VCs Crave and Cut Patent-Related Costs by 90%!How to Get the Patent Protection VCs Crave and Cut Patent-Related Costs by 90%!
How to Get the Patent Protection VCs Crave and Cut Patent-Related Costs by 90%!ideatoipo
 
REEXAMINATION - Dave Jones - 4-28-2007
REEXAMINATION - Dave Jones - 4-28-2007REEXAMINATION - Dave Jones - 4-28-2007
REEXAMINATION - Dave Jones - 4-28-2007David A. Jones
 
Patent Filing & Grant Procedures
Patent Filing & Grant ProceduresPatent Filing & Grant Procedures
Patent Filing & Grant ProceduresPooja Shree
 
Website Template 1
Website Template 1Website Template 1
Website Template 1legal4
 
New Strategies for Third Parties The Role of New Third Party Preissuance Sub...
New Strategies for Third Parties  The Role of New Third Party Preissuance Sub...New Strategies for Third Parties  The Role of New Third Party Preissuance Sub...
New Strategies for Third Parties The Role of New Third Party Preissuance Sub...Marc Hubbard
 
Webcast Slides--Gibson Dunn 2012 Year-End Report and Hot Topics
Webcast Slides--Gibson Dunn 2012 Year-End Report and Hot TopicsWebcast Slides--Gibson Dunn 2012 Year-End Report and Hot Topics
Webcast Slides--Gibson Dunn 2012 Year-End Report and Hot TopicsGareth Evans
 
Bar-Workshop-11-November-2019.FINAL_.pptx
Bar-Workshop-11-November-2019.FINAL_.pptxBar-Workshop-11-November-2019.FINAL_.pptx
Bar-Workshop-11-November-2019.FINAL_.pptxphilipjamero
 
Knobbe Martens Webinar Series: Strategic Considerations in Controlling the Sp...
Knobbe Martens Webinar Series: Strategic Considerations in Controlling the Sp...Knobbe Martens Webinar Series: Strategic Considerations in Controlling the Sp...
Knobbe Martens Webinar Series: Strategic Considerations in Controlling the Sp...Jason Rabuy
 
A Walk-through of Supplemental Examination
A Walk-through of Supplemental ExaminationA Walk-through of Supplemental Examination
A Walk-through of Supplemental ExaminationWorkman Nydegger
 
Patent Law Review - IP Year in Review CLE v2
Patent Law Review - IP Year in Review CLE v2Patent Law Review - IP Year in Review CLE v2
Patent Law Review - IP Year in Review CLE v2Bryan Beel
 

Similar to SKGF_Advisory_Strategies for Life Under the New USPTO Rules on Continuation and Claims Practice_2007 (20)

Accelerating Patent Prosecution
Accelerating Patent ProsecutionAccelerating Patent Prosecution
Accelerating Patent Prosecution
 
Five major differences between IPRs and invalidation proceedings
Five major differences between IPRs and invalidation proceedingsFive major differences between IPRs and invalidation proceedings
Five major differences between IPRs and invalidation proceedings
 
ANALYSIS OF PATENTS POST APPROVAL
ANALYSIS OF PATENTS POST APPROVALANALYSIS OF PATENTS POST APPROVAL
ANALYSIS OF PATENTS POST APPROVAL
 
How to Get the Patent Protection VCs Crave and Cut Patent-Related Costs by 90%!
How to Get the Patent Protection VCs Crave and Cut Patent-Related Costs by 90%!How to Get the Patent Protection VCs Crave and Cut Patent-Related Costs by 90%!
How to Get the Patent Protection VCs Crave and Cut Patent-Related Costs by 90%!
 
15 March 2016 - Law Institute of Victoria conference presentation.
15 March 2016 - Law Institute of Victoria conference presentation.15 March 2016 - Law Institute of Victoria conference presentation.
15 March 2016 - Law Institute of Victoria conference presentation.
 
Georgetown Univ. Law Center Conference: Post-Grant Patent Proceedings: Are th...
Georgetown Univ. Law Center Conference: Post-Grant Patent Proceedings: Are th...Georgetown Univ. Law Center Conference: Post-Grant Patent Proceedings: Are th...
Georgetown Univ. Law Center Conference: Post-Grant Patent Proceedings: Are th...
 
How to Get the Patent Protection VCs Crave and Cut Patent-Related Costs by 90%!
How to Get the Patent Protection VCs Crave and Cut Patent-Related Costs by 90%!How to Get the Patent Protection VCs Crave and Cut Patent-Related Costs by 90%!
How to Get the Patent Protection VCs Crave and Cut Patent-Related Costs by 90%!
 
Patent Trial and Appeal Board (PTAB) - Multi Petition Challenges of a Patent
Patent Trial and Appeal Board (PTAB) - Multi Petition Challenges of a PatentPatent Trial and Appeal Board (PTAB) - Multi Petition Challenges of a Patent
Patent Trial and Appeal Board (PTAB) - Multi Petition Challenges of a Patent
 
REEXAMINATION - Dave Jones - 4-28-2007
REEXAMINATION - Dave Jones - 4-28-2007REEXAMINATION - Dave Jones - 4-28-2007
REEXAMINATION - Dave Jones - 4-28-2007
 
Patent Filing & Grant Procedures
Patent Filing & Grant ProceduresPatent Filing & Grant Procedures
Patent Filing & Grant Procedures
 
Patent Prosecution Luncheon October 2012
Patent Prosecution Luncheon October 2012Patent Prosecution Luncheon October 2012
Patent Prosecution Luncheon October 2012
 
Website Template 1
Website Template 1Website Template 1
Website Template 1
 
New Strategies for Third Parties The Role of New Third Party Preissuance Sub...
New Strategies for Third Parties  The Role of New Third Party Preissuance Sub...New Strategies for Third Parties  The Role of New Third Party Preissuance Sub...
New Strategies for Third Parties The Role of New Third Party Preissuance Sub...
 
Federal Rules Update
Federal Rules UpdateFederal Rules Update
Federal Rules Update
 
Will the America Invents Act (AIA) Change Patent Litigation in the Eastern Di...
Will the America Invents Act (AIA) Change Patent Litigation in the Eastern Di...Will the America Invents Act (AIA) Change Patent Litigation in the Eastern Di...
Will the America Invents Act (AIA) Change Patent Litigation in the Eastern Di...
 
Webcast Slides--Gibson Dunn 2012 Year-End Report and Hot Topics
Webcast Slides--Gibson Dunn 2012 Year-End Report and Hot TopicsWebcast Slides--Gibson Dunn 2012 Year-End Report and Hot Topics
Webcast Slides--Gibson Dunn 2012 Year-End Report and Hot Topics
 
Bar-Workshop-11-November-2019.FINAL_.pptx
Bar-Workshop-11-November-2019.FINAL_.pptxBar-Workshop-11-November-2019.FINAL_.pptx
Bar-Workshop-11-November-2019.FINAL_.pptx
 
Knobbe Martens Webinar Series: Strategic Considerations in Controlling the Sp...
Knobbe Martens Webinar Series: Strategic Considerations in Controlling the Sp...Knobbe Martens Webinar Series: Strategic Considerations in Controlling the Sp...
Knobbe Martens Webinar Series: Strategic Considerations in Controlling the Sp...
 
A Walk-through of Supplemental Examination
A Walk-through of Supplemental ExaminationA Walk-through of Supplemental Examination
A Walk-through of Supplemental Examination
 
Patent Law Review - IP Year in Review CLE v2
Patent Law Review - IP Year in Review CLE v2Patent Law Review - IP Year in Review CLE v2
Patent Law Review - IP Year in Review CLE v2
 

More from SterneKessler

Focus on Pharma: Creating, Protecting & Enforcing High-Value IP Assets
Focus on Pharma: Creating, Protecting & Enforcing High-Value IP AssetsFocus on Pharma: Creating, Protecting & Enforcing High-Value IP Assets
Focus on Pharma: Creating, Protecting & Enforcing High-Value IP AssetsSterneKessler
 
SKGF_Advisory_USPTO Bio-Chem-Pharma Customer Partnership Meeting_2006
SKGF_Advisory_USPTO Bio-Chem-Pharma Customer Partnership Meeting_2006SKGF_Advisory_USPTO Bio-Chem-Pharma Customer Partnership Meeting_2006
SKGF_Advisory_USPTO Bio-Chem-Pharma Customer Partnership Meeting_2006SterneKessler
 
SKGF_Advisory_US Design Patents Strengthened by Recent Federal Circuit Ruling...
SKGF_Advisory_US Design Patents Strengthened by Recent Federal Circuit Ruling...SKGF_Advisory_US Design Patents Strengthened by Recent Federal Circuit Ruling...
SKGF_Advisory_US Design Patents Strengthened by Recent Federal Circuit Ruling...SterneKessler
 
SKGF_Advisory_Two Questions Every Wind Energy Company Should Ask Itself_2009
SKGF_Advisory_Two Questions Every Wind Energy Company Should Ask Itself_2009SKGF_Advisory_Two Questions Every Wind Energy Company Should Ask Itself_2009
SKGF_Advisory_Two Questions Every Wind Energy Company Should Ask Itself_2009SterneKessler
 
SKGF_Advisory_The Blackberry Saga_2006
SKGF_Advisory_The Blackberry Saga_2006SKGF_Advisory_The Blackberry Saga_2006
SKGF_Advisory_The Blackberry Saga_2006SterneKessler
 
SKGF_Advisory_SKGF Forms Stem Cell Task Force Advisory_2005
SKGF_Advisory_SKGF Forms Stem Cell Task Force Advisory_2005SKGF_Advisory_SKGF Forms Stem Cell Task Force Advisory_2005
SKGF_Advisory_SKGF Forms Stem Cell Task Force Advisory_2005SterneKessler
 
SKGF_Advisory_Reexamination Practice with Concurrent District Court or USITC ...
SKGF_Advisory_Reexamination Practice with Concurrent District Court or USITC ...SKGF_Advisory_Reexamination Practice with Concurrent District Court or USITC ...
SKGF_Advisory_Reexamination Practice with Concurrent District Court or USITC ...SterneKessler
 
SKGF_Advisory_Real World Impacts of Reexamination Practice and Procedure_2008
SKGF_Advisory_Real World Impacts of Reexamination Practice and Procedure_2008SKGF_Advisory_Real World Impacts of Reexamination Practice and Procedure_2008
SKGF_Advisory_Real World Impacts of Reexamination Practice and Procedure_2008SterneKessler
 
SKGF_Advisory_Preparing and Prosecuting a Patent that Holds up in Litigation_...
SKGF_Advisory_Preparing and Prosecuting a Patent that Holds up in Litigation_...SKGF_Advisory_Preparing and Prosecuting a Patent that Holds up in Litigation_...
SKGF_Advisory_Preparing and Prosecuting a Patent that Holds up in Litigation_...SterneKessler
 
SKGF_Advisory_Living in a Post KSR World_2007
SKGF_Advisory_Living in a Post KSR World_2007SKGF_Advisory_Living in a Post KSR World_2007
SKGF_Advisory_Living in a Post KSR World_2007SterneKessler
 
SKGF_Advisory_Federal Circuit Issues Decision in TAFAS v. Doll_2009
SKGF_Advisory_Federal Circuit Issues Decision in TAFAS v. Doll_2009SKGF_Advisory_Federal Circuit Issues Decision in TAFAS v. Doll_2009
SKGF_Advisory_Federal Circuit Issues Decision in TAFAS v. Doll_2009SterneKessler
 
SKGF_Advisory_Stem Cells-Patent Pools to the Rescue_2005
SKGF_Advisory_Stem Cells-Patent Pools to the Rescue_2005SKGF_Advisory_Stem Cells-Patent Pools to the Rescue_2005
SKGF_Advisory_Stem Cells-Patent Pools to the Rescue_2005SterneKessler
 
SKGF_Advisory_Nanotechnology Practice News_2005
SKGF_Advisory_Nanotechnology Practice News_2005SKGF_Advisory_Nanotechnology Practice News_2005
SKGF_Advisory_Nanotechnology Practice News_2005SterneKessler
 
SKGF_Presentation_What You Need To Know About The Proposed USPTO Rule Changes...
SKGF_Presentation_What You Need To Know About The Proposed USPTO Rule Changes...SKGF_Presentation_What You Need To Know About The Proposed USPTO Rule Changes...
SKGF_Presentation_What You Need To Know About The Proposed USPTO Rule Changes...SterneKessler
 
SKGF_Presentation_The Supreme Courts Renewed Interest In IP_April 2007
SKGF_Presentation_The Supreme Courts Renewed Interest In IP_April 2007SKGF_Presentation_The Supreme Courts Renewed Interest In IP_April 2007
SKGF_Presentation_The Supreme Courts Renewed Interest In IP_April 2007SterneKessler
 
SKGF_Presentation_The Gate Intellectual Property Groundwork_2004
SKGF_Presentation_The Gate Intellectual Property Groundwork_2004SKGF_Presentation_The Gate Intellectual Property Groundwork_2004
SKGF_Presentation_The Gate Intellectual Property Groundwork_2004SterneKessler
 
SKGF_Presentation_Stem Cells The Patent Landscape_2005
SKGF_Presentation_Stem Cells The Patent Landscape_2005SKGF_Presentation_Stem Cells The Patent Landscape_2005
SKGF_Presentation_Stem Cells The Patent Landscape_2005SterneKessler
 
SKGF_Presentation_SKGF Nanotube Patent Study_2004
SKGF_Presentation_SKGF Nanotube Patent Study_2004SKGF_Presentation_SKGF Nanotube Patent Study_2004
SKGF_Presentation_SKGF Nanotube Patent Study_2004SterneKessler
 
SKGF_Presentation_Nanotechnology IP Licensing Think Big, But Keep Your Feet O...
SKGF_Presentation_Nanotechnology IP Licensing Think Big, But Keep Your Feet O...SKGF_Presentation_Nanotechnology IP Licensing Think Big, But Keep Your Feet O...
SKGF_Presentation_Nanotechnology IP Licensing Think Big, But Keep Your Feet O...SterneKessler
 
SKGF_Presentation_Intellectual Property Exploitation Strategies_2003
SKGF_Presentation_Intellectual Property Exploitation Strategies_2003SKGF_Presentation_Intellectual Property Exploitation Strategies_2003
SKGF_Presentation_Intellectual Property Exploitation Strategies_2003SterneKessler
 

More from SterneKessler (20)

Focus on Pharma: Creating, Protecting & Enforcing High-Value IP Assets
Focus on Pharma: Creating, Protecting & Enforcing High-Value IP AssetsFocus on Pharma: Creating, Protecting & Enforcing High-Value IP Assets
Focus on Pharma: Creating, Protecting & Enforcing High-Value IP Assets
 
SKGF_Advisory_USPTO Bio-Chem-Pharma Customer Partnership Meeting_2006
SKGF_Advisory_USPTO Bio-Chem-Pharma Customer Partnership Meeting_2006SKGF_Advisory_USPTO Bio-Chem-Pharma Customer Partnership Meeting_2006
SKGF_Advisory_USPTO Bio-Chem-Pharma Customer Partnership Meeting_2006
 
SKGF_Advisory_US Design Patents Strengthened by Recent Federal Circuit Ruling...
SKGF_Advisory_US Design Patents Strengthened by Recent Federal Circuit Ruling...SKGF_Advisory_US Design Patents Strengthened by Recent Federal Circuit Ruling...
SKGF_Advisory_US Design Patents Strengthened by Recent Federal Circuit Ruling...
 
SKGF_Advisory_Two Questions Every Wind Energy Company Should Ask Itself_2009
SKGF_Advisory_Two Questions Every Wind Energy Company Should Ask Itself_2009SKGF_Advisory_Two Questions Every Wind Energy Company Should Ask Itself_2009
SKGF_Advisory_Two Questions Every Wind Energy Company Should Ask Itself_2009
 
SKGF_Advisory_The Blackberry Saga_2006
SKGF_Advisory_The Blackberry Saga_2006SKGF_Advisory_The Blackberry Saga_2006
SKGF_Advisory_The Blackberry Saga_2006
 
SKGF_Advisory_SKGF Forms Stem Cell Task Force Advisory_2005
SKGF_Advisory_SKGF Forms Stem Cell Task Force Advisory_2005SKGF_Advisory_SKGF Forms Stem Cell Task Force Advisory_2005
SKGF_Advisory_SKGF Forms Stem Cell Task Force Advisory_2005
 
SKGF_Advisory_Reexamination Practice with Concurrent District Court or USITC ...
SKGF_Advisory_Reexamination Practice with Concurrent District Court or USITC ...SKGF_Advisory_Reexamination Practice with Concurrent District Court or USITC ...
SKGF_Advisory_Reexamination Practice with Concurrent District Court or USITC ...
 
SKGF_Advisory_Real World Impacts of Reexamination Practice and Procedure_2008
SKGF_Advisory_Real World Impacts of Reexamination Practice and Procedure_2008SKGF_Advisory_Real World Impacts of Reexamination Practice and Procedure_2008
SKGF_Advisory_Real World Impacts of Reexamination Practice and Procedure_2008
 
SKGF_Advisory_Preparing and Prosecuting a Patent that Holds up in Litigation_...
SKGF_Advisory_Preparing and Prosecuting a Patent that Holds up in Litigation_...SKGF_Advisory_Preparing and Prosecuting a Patent that Holds up in Litigation_...
SKGF_Advisory_Preparing and Prosecuting a Patent that Holds up in Litigation_...
 
SKGF_Advisory_Living in a Post KSR World_2007
SKGF_Advisory_Living in a Post KSR World_2007SKGF_Advisory_Living in a Post KSR World_2007
SKGF_Advisory_Living in a Post KSR World_2007
 
SKGF_Advisory_Federal Circuit Issues Decision in TAFAS v. Doll_2009
SKGF_Advisory_Federal Circuit Issues Decision in TAFAS v. Doll_2009SKGF_Advisory_Federal Circuit Issues Decision in TAFAS v. Doll_2009
SKGF_Advisory_Federal Circuit Issues Decision in TAFAS v. Doll_2009
 
SKGF_Advisory_Stem Cells-Patent Pools to the Rescue_2005
SKGF_Advisory_Stem Cells-Patent Pools to the Rescue_2005SKGF_Advisory_Stem Cells-Patent Pools to the Rescue_2005
SKGF_Advisory_Stem Cells-Patent Pools to the Rescue_2005
 
SKGF_Advisory_Nanotechnology Practice News_2005
SKGF_Advisory_Nanotechnology Practice News_2005SKGF_Advisory_Nanotechnology Practice News_2005
SKGF_Advisory_Nanotechnology Practice News_2005
 
SKGF_Presentation_What You Need To Know About The Proposed USPTO Rule Changes...
SKGF_Presentation_What You Need To Know About The Proposed USPTO Rule Changes...SKGF_Presentation_What You Need To Know About The Proposed USPTO Rule Changes...
SKGF_Presentation_What You Need To Know About The Proposed USPTO Rule Changes...
 
SKGF_Presentation_The Supreme Courts Renewed Interest In IP_April 2007
SKGF_Presentation_The Supreme Courts Renewed Interest In IP_April 2007SKGF_Presentation_The Supreme Courts Renewed Interest In IP_April 2007
SKGF_Presentation_The Supreme Courts Renewed Interest In IP_April 2007
 
SKGF_Presentation_The Gate Intellectual Property Groundwork_2004
SKGF_Presentation_The Gate Intellectual Property Groundwork_2004SKGF_Presentation_The Gate Intellectual Property Groundwork_2004
SKGF_Presentation_The Gate Intellectual Property Groundwork_2004
 
SKGF_Presentation_Stem Cells The Patent Landscape_2005
SKGF_Presentation_Stem Cells The Patent Landscape_2005SKGF_Presentation_Stem Cells The Patent Landscape_2005
SKGF_Presentation_Stem Cells The Patent Landscape_2005
 
SKGF_Presentation_SKGF Nanotube Patent Study_2004
SKGF_Presentation_SKGF Nanotube Patent Study_2004SKGF_Presentation_SKGF Nanotube Patent Study_2004
SKGF_Presentation_SKGF Nanotube Patent Study_2004
 
SKGF_Presentation_Nanotechnology IP Licensing Think Big, But Keep Your Feet O...
SKGF_Presentation_Nanotechnology IP Licensing Think Big, But Keep Your Feet O...SKGF_Presentation_Nanotechnology IP Licensing Think Big, But Keep Your Feet O...
SKGF_Presentation_Nanotechnology IP Licensing Think Big, But Keep Your Feet O...
 
SKGF_Presentation_Intellectual Property Exploitation Strategies_2003
SKGF_Presentation_Intellectual Property Exploitation Strategies_2003SKGF_Presentation_Intellectual Property Exploitation Strategies_2003
SKGF_Presentation_Intellectual Property Exploitation Strategies_2003
 

Recently uploaded

Passkey Providers and Enabling Portability: FIDO Paris Seminar.pptx
Passkey Providers and Enabling Portability: FIDO Paris Seminar.pptxPasskey Providers and Enabling Portability: FIDO Paris Seminar.pptx
Passkey Providers and Enabling Portability: FIDO Paris Seminar.pptxLoriGlavin3
 
Moving Beyond Passwords: FIDO Paris Seminar.pdf
Moving Beyond Passwords: FIDO Paris Seminar.pdfMoving Beyond Passwords: FIDO Paris Seminar.pdf
Moving Beyond Passwords: FIDO Paris Seminar.pdfLoriGlavin3
 
Connect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationConnect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationSlibray Presentation
 
Commit 2024 - Secret Management made easy
Commit 2024 - Secret Management made easyCommit 2024 - Secret Management made easy
Commit 2024 - Secret Management made easyAlfredo García Lavilla
 
SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024Lorenzo Miniero
 
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptx
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptxThe Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptx
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptxLoriGlavin3
 
Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsRizwan Syed
 
The Ultimate Guide to Choosing WordPress Pros and Cons
The Ultimate Guide to Choosing WordPress Pros and ConsThe Ultimate Guide to Choosing WordPress Pros and Cons
The Ultimate Guide to Choosing WordPress Pros and ConsPixlogix Infotech
 
Use of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptx
Use of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptxUse of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptx
Use of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptxLoriGlavin3
 
Unleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubUnleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubKalema Edgar
 
Generative AI for Technical Writer or Information Developers
Generative AI for Technical Writer or Information DevelopersGenerative AI for Technical Writer or Information Developers
Generative AI for Technical Writer or Information DevelopersRaghuram Pandurangan
 
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024BookNet Canada
 
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptx
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptxMerck Moving Beyond Passwords: FIDO Paris Seminar.pptx
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptxLoriGlavin3
 
New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024
New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024
New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024BookNet Canada
 
Gen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfGen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfAddepto
 
SAP Build Work Zone - Overview L2-L3.pptx
SAP Build Work Zone - Overview L2-L3.pptxSAP Build Work Zone - Overview L2-L3.pptx
SAP Build Work Zone - Overview L2-L3.pptxNavinnSomaal
 
Ensuring Technical Readiness For Copilot in Microsoft 365
Ensuring Technical Readiness For Copilot in Microsoft 365Ensuring Technical Readiness For Copilot in Microsoft 365
Ensuring Technical Readiness For Copilot in Microsoft 3652toLead Limited
 
Take control of your SAP testing with UiPath Test Suite
Take control of your SAP testing with UiPath Test SuiteTake control of your SAP testing with UiPath Test Suite
Take control of your SAP testing with UiPath Test SuiteDianaGray10
 
"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii SoldatenkoFwdays
 
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024BookNet Canada
 

Recently uploaded (20)

Passkey Providers and Enabling Portability: FIDO Paris Seminar.pptx
Passkey Providers and Enabling Portability: FIDO Paris Seminar.pptxPasskey Providers and Enabling Portability: FIDO Paris Seminar.pptx
Passkey Providers and Enabling Portability: FIDO Paris Seminar.pptx
 
Moving Beyond Passwords: FIDO Paris Seminar.pdf
Moving Beyond Passwords: FIDO Paris Seminar.pdfMoving Beyond Passwords: FIDO Paris Seminar.pdf
Moving Beyond Passwords: FIDO Paris Seminar.pdf
 
Connect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationConnect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck Presentation
 
Commit 2024 - Secret Management made easy
Commit 2024 - Secret Management made easyCommit 2024 - Secret Management made easy
Commit 2024 - Secret Management made easy
 
SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024
 
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptx
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptxThe Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptx
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptx
 
Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL Certs
 
The Ultimate Guide to Choosing WordPress Pros and Cons
The Ultimate Guide to Choosing WordPress Pros and ConsThe Ultimate Guide to Choosing WordPress Pros and Cons
The Ultimate Guide to Choosing WordPress Pros and Cons
 
Use of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptx
Use of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptxUse of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptx
Use of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptx
 
Unleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubUnleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding Club
 
Generative AI for Technical Writer or Information Developers
Generative AI for Technical Writer or Information DevelopersGenerative AI for Technical Writer or Information Developers
Generative AI for Technical Writer or Information Developers
 
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
 
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptx
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptxMerck Moving Beyond Passwords: FIDO Paris Seminar.pptx
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptx
 
New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024
New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024
New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024
 
Gen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfGen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdf
 
SAP Build Work Zone - Overview L2-L3.pptx
SAP Build Work Zone - Overview L2-L3.pptxSAP Build Work Zone - Overview L2-L3.pptx
SAP Build Work Zone - Overview L2-L3.pptx
 
Ensuring Technical Readiness For Copilot in Microsoft 365
Ensuring Technical Readiness For Copilot in Microsoft 365Ensuring Technical Readiness For Copilot in Microsoft 365
Ensuring Technical Readiness For Copilot in Microsoft 365
 
Take control of your SAP testing with UiPath Test Suite
Take control of your SAP testing with UiPath Test SuiteTake control of your SAP testing with UiPath Test Suite
Take control of your SAP testing with UiPath Test Suite
 
"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko
 
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
 

SKGF_Advisory_Strategies for Life Under the New USPTO Rules on Continuation and Claims Practice_2007

  • 1. Strategies for Life Under the New USPTO Rules on Continuation and Claims Practice Elizabeth Haanes, Ph.D., Esq. Mike Messinger, Esq. Michele A. Cimbala Ph.D., Esq. September 18, 2007
  • 2. Strategies for Life Under the New USPTO Rules • Rational Responses – Sell All Your Belongings – Stop Innovating and – Live in a Cave
  • 3. Notice of Final Rulemaking • “Changes to Practice for Continued Examination Filings, Patent Applications Containing Patentably Indistinct Claims, and Examination of Claims in Patent Applications” – 72 Fed. Reg. 46716 (August 21, 2007) • Effective: November 1, 2007 (but much is retroactive)
  • 4. Key Provisions • The number of examined claims will be limited (Rule 75) • The number of continuation or CIP applications in a family will be limited, and voluntary divisional applications will not be allowed (Rule 78(d)) • Only one RCE per application family (Rule 114) • Applicants will be required to identify certain copending, commonly-owned applications which share a common inventor (Rule 78(f))
  • 5. The Good News... • Excess claim fees paid for unexamined, canceled claims will be refunded upon request • Applicants may now propose a “suggested restriction requirement” (SRR) to the Examiner • Streamlined Continuations – may request continuations to be placed on Examiner’s Amended Docket
  • 6. The Bad News... • Only 5 independent and 25 total claims will be examined in any application without an “examination support document” (ESD) • Commonly owned applications with common subject matter, a common inventor, or both, must be identified • Typically only two continuation or CIP applications and one RCE per family “as of right” • No voluntary divisional applications
  • 7. The REALLY Bad News • Examination Support Documents • Copending applications determined to have “patentably indistinct” claims will be combined to meet the 5/25 claim rule
  • 8. SKGF is Here to Help You!
  • 9. What We are Doing Already • First Client Advisory Letter (Aug. 30) • Second Client Advisory Letter (in draft) • Triaged File Review • Staffing • Automation – Support for New Search Queries and Reports • Docketing – New Rules and Dates • Internal and External Training • Frequent Involvement with USPTO
  • 10. Rule 75 - Claims • The maximum number of examined claims per “non-allowed” application as a matter of right: – 5 independent claims – 25 total claims • An “Examination Support Document” (ESD) under 37 C.F.R. 1.265 must be submitted if you are not in compliance with Rule 75 • Withdrawn claims do not count against the 5/25 limit unless they are reinstated or rejoined
  • 11. Rule 75 - Claims • The number of claims in applications that are co-owned and that contain at least one “patentably indistinct” claim will be added together for the purposes of counting the total number of claims. • Once an application is allowed, a continuing application (CON or CIP) can be filed with another set of claims that complies with the 5/25 rule (“serial continuations”) • Reissue applications must comply with the 5/25 limit.
  • 12. Rule 75 - Claims • If two or more pending, co-owned applications contain patentably indistinct claims, the USPTO will require the combined claims in those applications to meet the 5/25 limit
  • 13. Rule 75 • If the application is not in compliance with Rule 75 and it appears this was inadvertent, Applicant will be sent a notice with a 2 month period (not extendable) to: – supply an ESD; – Cancel claims; or – Submit a suggested restriction accompanied by an election without traverse to an invention drawn to a group that is in compliance.
  • 14. Rule 75 is “Retroactive” • applies to any application that has not yet received a first office action on the merits (“FAOM”) by November 1, 2007
  • 15. Ways Around 5/25 • Prosecute CONs Serially – File after Parent Allowed • SRR • ESD
  • 16. Suggested Restriction Requirements (SRR) • New practice under rule 142 -- Applicant can submit a suggested restriction requirement (SRR) BUT – It must be filed prior to the first action on merits or first action that contains a restriction or lack of unity – An SRR must be accompanied by an election without traverse of an invention that complies with the 5/25 claim number requirement
  • 17. SRRs • The Examiner can: – accept the SRR and commence examination on the elected group of claims; – reject the SRR and issue a different restriction requirement (Applicant must elect a group of claims and conform limit claims to 5/25); or – or reject the SRR and issue NO restriction requirement (Applicant must then limit claims to 5/25)
  • 18. Rule 265: Examination Support Document Requirements • A statement that a preexamination search has been conducted • A listing of references deemed most closely related to the subject matter of each claim • For each reference an identification of all of the limitations of each of the claims that are disclosed by the reference • A detailed explanation of how each of the independent claims is patentable over the cited references • A showing of where each limitation of each of the claims finds enablement and written description support in the specification and any priority applications
  • 19. ESD Recommendation • Avoid them where possible • Expensive and ripe for estoppel • May have to file Supplemental ESD(s) • See new ESD Guidelines issued Sept. 6
  • 20. More Strategy Recommendations – Claims Practice • Currently pending cases: – After FINAL and RCE - Consider RCE by Nov. 1 – After First Action on Merits – no claims limit yet – watch out if next action is expected to be a final – If restriction requirement pending, reply ASAP to try to receive first action on the merits prior to Nov. 1, 2007 – No FAOM issued prior to Nov. 1, 2007: • Consider SRR and election
  • 21. Strategy Recommendations • Future cases – new filings – Keep in mind 5/25 limit for appl. and 15/75 limit for appl. family – Draft claims with an eye toward restriction and divisional filings – PTO wants generic claims fully prosecuted first • Thin or Fat Initial Applications? – File Multiple Thin Initial Applications on same or different dates • Catch – ID requirement, Possible Merger, Terminal Disclaimer + Show why applications cannot be in one application – File Single Fat Application with many claims • Catch – SRR/Divisionals at Examiner’s discretion, SRR may have to argue one-way distinctness • No easy solution where substantial amount of overlapping material needs to be claimed • We will pull all this together in an example later
  • 22. How will the 5/25 Rule Effect USPTO Restriction Practice? • Examiners may be motivated to limit the restrictions to reduce claims examined in any one application family; BUT • Given the USPTO count system and time restrictions on Examiners, incentive remains for Examiners to issue restriction requirements to create more work on familiar applications • Time will tell...
  • 23. Identification of Copending Applications under Rule 78(f)(1) • Plan to be Aggravated • Burdensome, No Way Around It • How to Cope • SKGF May Need Your Help
  • 24. Identification of Copending Applications under Rule 78(f)(1) • Applicant must identify – all non-provisional applications/patents (that have not been allowed) that have benefit or filing dates within 2 months of each other – that name at least one common inventor and – that are owned/subject to assignment to the same entity • must provide within 4 months of filing or entering U.S. national phase • required even if the applications do not have similar subject matter
  • 25. Identification of Copending Applications under Rule 78(f)(1) • Rule is retroactive! • Applicants MUST comply with new rule 78(f)(1) in ALL pending applications by: FEBRUARY 1, 2008. • Intervening filing dates of Cons/Divs/CIPs should be considered as well
  • 26. Treatment of Copending Applications under Rule 78(f)(2) • If identification under 78(f)(1) required AND - multiple applications have the same filing or benefit date; - and contain “substantial overlapping disclosure - Then a rebuttable presumption exists that the applications each contain at least one claim that is not patentably distinct from at least one claim in the other application
  • 27. Treatment of Copending Applications under Rule 78(f)(2) • Applicants must rebut the presumption that the claims are patentably indistinct; OR • Submit a terminal disclaimer AND explain why the claims cannot be in a single application
  • 28. Compliance with Rule 78(f)(2) is by the later of • 4 months from the filing or national stage entry date • the date on which a claim that is not patentably distinct is presented • two months from the date of mailing of the initial filing receipt in any of the applications
  • 29. Rule 78(f)(2) is Retroactive! • Compliance with rule 78(f)(2) for all pending applications is required by February 1, 2008
  • 30. Ways Around the ID requirement • There are none – Inventorship determination is a matter of law – Staggering filing dates may raise other issues – Big burden for complex older patent families • What happens if we don’t comply... – Don’t go there intentionally • Best route – Apply experienced legal talent to benefit claim analysis – Automate like crazy with oversight – Look at your benefit claim data NOW
  • 31. SKGF Action • Prior to Feb. 1, 2008, SKGF will work with clients to identify all pending applications which require cross-identification under rule 78(f) • We will need client input as to whether additional applications (prosecuted in-house or by other firms) need to be identified
  • 32. Domestic Benefit Claims Rule 78(d) (d)(1) All domestic benefit claims MUST satisfy at least one of (d)(1)(i) through (d)(1)(vi) NB! The PTO is not responsible for its own errors: (d)(1): A mistake on the part of the PTO in entering or in not deleting an improper claim does not constitute a waiver of Rule 78(d)(1).
  • 33. Domestic Benefit Claims The Basics: • Only two continuation applications “as of right” • Each divisional may have its own two con applns. • No voluntary divisionals • No CIP’s filed off of divisionals
  • 34. Domestic Benefit Claims Organization of Rule 78(d) (d)(1)(i) - continuation appln (ii) - divisional appln (iii) - continuation of divisional appln (iv) - 1st nonprov is a Chap. I PCT; no fee paid and no Chap. II demand (v) - 1st nonprov appln was abandoned with a NTFMP (vi) - appln has a “petition and showing”
  • 35. “Continuing” Applications • A “Continuing Application” is a nonprovisional or PCT application designating the US that claims benefit of a prior filed nonprovisional or PCT application designating the US – Includes: continuation, divisional, continuation-in-part or PCT applications – Does NOT include: • A first filed nonprovisional application • A provisional application • An application that only has a benefit claim to a provisional application or a priority claim to a foreign application
  • 36. Continuation Applications Definition: • A continuing application that discloses and claims only subject matter that was disclosed in a prior- filed non-provisional application
  • 37. Continuation-in-Part (CIP) Applications • A continuing application that discloses subject matter that was not disclosed in a prior-filed non-provisional application • Applicants must identify claims in a CIP that have 35 U.S.C. 112(1) support in the earlier-filed non-provisional application • Any claim not so identified will be presumed to be entitled only to the filing date of the CIP
  • 38. CIP Recommendations • Avoid them. If claims are supported by the earlier-filed non-provisional application, use a continuation rather than a CIP • If the claims would not be supported by the earlier-filed non- provisional application, consider filing a new application without claiming priority benefit
  • 39. Recommendation: Postpone “Continuing” Applications • Now: consider converting first-filed U.S. nonprovisional filings to provisionals • Future: file initial filings in the United States as provisional applications
  • 40. “Showing” Standard for Additional Continuing Applications • Must include an amendment, argument, or evidence • Must show that the information sought to be entered could not have been submitted during the prosecution of the prior-filed application • Must be submitted within 4 months from the filing date, or national stage entry date, of the continuing application.
  • 41. Divisional Applications • A divisional application is a continuing application that discloses and claims only inventions subject to a lack of unity or restriction in a prior- filed application, and that were – Not elected in the prior application; and – Not examined in any prior application. • A “voluntary divisional” is a continuation
  • 42. Divisionals • Can I rely upon a restriction requirement to immediately file a divisional? – Yes, if you elect without traverse, and cancel all non-elected claims – No, if you traverse the restriction, because there is a chance it will be withdrawn – No, if you retain non-elected claims, because they might be rejoined
  • 43. “Not Examined in Any Prior-filed Application” • Does “Examined” encompass PCT Chapter II “preliminary examination” ? • YES (?) NO(?) <PTO must clarify> • Thus, during later US prosecution a lack of unity rejection or restriction requirement is made, it may not be possible to file a proper “divisional” application on claims which were already subject to PCT Chapter II preliminary examination
  • 44. What if Restricted Claims Have Been Examined? • Elect those claims which have already been examined • Traverse the restriction requirement and petition finality • File the already-examined but restricted claims in a “continuation” with a petition and showing
  • 45. RCEs • Only 1 RCE as of right in any application family • Additional RCEs will require a petition, fee, and a sufficient “showing” that the amendment, argument, or evidence sought to be submitted couldn’t have been submitted prior to close of prosecution in the application • For subsequent RCEs, an IDS, by itself, is an insufficient “showing” • Is it not sufficient that the Examiner raised new grounds of rejection in a final office action.
  • 46. RCE and “After Final” Recommendations • NOW: if you currently have a final rejection and have already filed one RCE in the family, file a second RCE prior to November 1, 2007 • Going forward: petition improper final office actions • Use interview practice to negotiate allowable claims • If further continuations are not an option, amend claims to put in best form for appeal
  • 47. Example, Continuations Filed Before 8/21/07 8/21/07 11/1/07 2nd Con Con Con Con • Benefit claim will be ok but if not yet examined, will still have to comply with the 5/25 rule. • Applications must comply with the identification requirements of Rule 78(f)
  • 48. Filing Con before 11/1/07 8/21/07 11/1/07 2nd Con Con Con Con These are 3rd – 5th Continuations; No “one more exception” (OME) will be available after 11/1 5/25 will apply and also identification Rule 78(f)(1) and (2) The PTO can force you to combine all the continuations.
  • 49. So is it wise to file continuations before November 1? Filing Cons after 8/21/07 and before 11/1/07 won’t help and may hurt.
  • 50. New Mindset for Focused Examination • Impact on New Filings and Patent Portfolio Creation • Maximize Value of an Application Family (Initial Appl./2 CONs) – Target claims even better upfront – Consider more “story” in specification or evidence on non-obviousness – Consider more patentability searching (Seagate) – Know Prosecution Strategy, Desired Claim Coverage and Endgame Upfront • More Pitfalls - Patent Prosecution Expertise and Time for Analysis Even More Important
  • 51. First Example of Life Under the New Rules Example – Wireless Web Phone Functionality Invention
  • 52. Example of Life Under the New Rules
  • 53. First Example of Life Under the New Rules
  • 54. Example of Life Under the New Rules
  • 57. New Mindset for Focused Examinaton • The New Skill Set – Suggesting restrictions • Arguing one-way distinctness – Petitioning Improper Final Office Action – Interviewing • before and after Office Actions if possible – More Appeals to BPAI – Concise Claiming – Tracking Claim Count – Identifying Commonly-Owned Applications with a Common Inventor even across multiple prosecution firms
  • 58. To Do List – SKGF and Clients • Our Actions Items - SKGF and Clients – Now to Nov. 1, 2007 • Get Grandfathered – Respond to Restriction Requirements – File RCEs after Final – Now to Feb. 1, 2008 • Review and Collect Data for ID Req’t – Special Cases to Call Your Attorney • New Continuations to Cover Unclaimed Subject Matter • Pending Cases with Very High Claim Counts • Complex Benefit Claims
  • 59. THANK YOU! Elizabeth Haanes, Ph.D., Esq. bhaanes@SKGF.com Mike Messinger, Esq. mikem@SKGF.com Michele A. Cimbala, Ph.D., Esq. mcimbala@SKGF.com This content of this presentation by Sterne, Kessler, Goldstein & Fox P.L.L.C. is for purposes of discussion and should not be considered legal advice. © 2007 Sterne, Kessler, Goldstein & Fox P.L.L.C. 722854